On Nov. 20, 2020, researchers at the Broad Institute of MIT and Harvard announced they had developed a new COVID-19 test called SHINE that can identify 90 percent of samples with the SARS-CoV-2 virus and 100 percent of negative samples compared to the gold-standard RT-qPCR test. The test, still in the research stage, doesnﾒt require bulky and expensive equipment and could one day enable SARS-CoV-2 testing outside of hospitals and labs.